Published in Vaccine Weekly, August 12th, 1996
Analysis of a person who became infected with HIV after having a good response to an experimental HIV vaccine shows that the virus can alter the ability of T helper cells to recognize co-infecting variants.
"Our findings confirm the impression that strain variability will be a major obstacle for vaccine development," said Stephen J. Kent of the University of Washington, Seattle.
Kent discussed his findings at the XI International Conference on AIDS, held July 7-12, 1996 in Vancouver, British Columbia, Canada.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly